Dr. Julian Gillmore, Dr. David Lebwohl, and Dr. C. Michael Gibson Discuss: First-in-Human in vivo Crispr/Cas9 Editing of the Ttr Gene by Ntla-2001 in Patients with Transthyretin Amyloidosis With Cardiomyopathy